| Moffitt Looking For Participants In New Ovarian Cancer Trial
Women suffering from recurrent ovarian cancer may have a new treatment regimen that may increase the response to treatment and prolong their lives. Doctors at H. Lee Moffitt Cancer Center & Research Institute are testing a combination of chemotherapy and the drug Avastin in these patients. Moffitt opened a clinical trial recently and is looking for new participants for the study.
"We can often get the cancer to shrink for periods of time, but ultimately, it becomes resistant to standard chemotherapies," said Dr. Robert Wenham, member of the gynecologic oncology program at Moffitt. "The hope is that by using these targeted therapies, we can prolong and manage the cancer making it more of a chronic disease process rather than something that's going to take the patient's life."
The clinical trial will address ovarian cancers that are incurable and tough to treat.
Antwerp radiotherapy centre chooses TomoTherapy cancer treatment ...
Madison, Wis., USA. The new University Radiotherapy Centre of Antwerp has chosen the TomoTherapy HiArt treatment system for providing radiation therapy, and the Centre will serve as a European training facility for TomoTherapy Incorporated (NASDAQ: TTPY). Hospitals participating in the Centre include University Hospital Antwerp and the Antwerp City Hospital Network. Two HiArt treatment systems have been installed on-site at University Hospital Antwerp. Through the University Radiotherapy Center, both member hospitals will use HiArt treatment systems to treat cancer patients with advanced image-guided, intensity-modulated radiation therapy (IG/IMRT). And, through collaboration with TomoTherapy, the machines will also be available for training physicians, hospital staff and TomoTherapy employees while still providing uninterrupted patient care.
Unlocking cancer's secrets
PREDICT is the B.C. Cancer Agency's new research project at its Vancouver Island centre. An acronym for Personalized Response Determinants in Cancer Therapy, the program could just as easily have been tagged SMART -- simple, measurable, achievable, realistic and timely.
.
|
